Green Synthetic Routes for Active Pharmaceutical Ingredients (APIs): A Comprehensive Review Recent Advances, Sustainable Methodologies, and Industrial Applications in Pharmaceutical Chemistry
Year: 2026
Type: article
Abstract: Synthesizing pharmaceutical compounds demands exceptionally high structural precision, regio-selectivity, and absolute enantiomeric purity. Historically, reaching these target quality standards relied heavily on volatile organic solvents, heavy-metal catalysts, and multi-step protection strategies. Consequently, active pharmaceutical ingredient (API) production has generated disproportionately high Environmental Factors (E-factors, measured as kilograms of waste per kilogram of finalized drug product) compared to generic chemical sectors. Fundamental Paradigms: To resolve these sustainability hurdles, Anastas and Warner established foundational guidelines that prioritize waste elimination at the chemical design stage. Within active pharmaceutical synthesis, key priorities include:
Language: English
Subfield: Environmental Chemistry
Field: Environmental Science
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7236311016
